Nicolaos Anagnostopoulos

Thalidomide and dexamethasone combination for refractory multiple myeloma

Meletios Α. Dimopoulos, Konstantinos Zervas, G. Kouvatseas et al. · Annals of Oncology · 2001 · 282 citations · Full text

Medicine, Hematology, Oncology +13

Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study

Helen Giamarellou, Evangelos J. Giamarellos‐Bourboulis, Panagiotis Repoussis et al. · Clinical Microbiology and Infection · 2004 · 96 citations · Full text

Medicine, Hematology, Medical Microbiology +7

VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group

Konstantinos Zervas, Dimitra Mihou, Eirini Katodritou et al. · Annals of Oncology · 2007 · 66 citations · Full text

Medicine, Hematology, Oncology +14

Survival and prognostic factors after initiation of treatment in Waldenstrom’s macroglobulinemia

Meletios Α. Dimopoulos, George Hamilos, Konstantinos Zervas et al. · Annals of Oncology · 2003 · 52 citations

Medicine, Hematology, Oncology +3

Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent

Athanasios Zomas, Nicolaos Anagnostopoulos · Bone Marrow Transplantation · 2000 · 48 citations

Medicine, Hematology, Oncology +17